. 2Fo-Fc electron density map of apo Pds5 at 3.2 Å resolution. Related to Figure 1A . The map was contoured at 1.2 σ level. Inset: close up of a section of the spine, showing approximately residues 370-470. The electron density map was of excellent quality except the very N-and C-terminal sections, most likely through disorder in the crystals.
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Supplemental Figure S1
Electron density map supporting the main finding of the paper, the crystal structure of Pds5 (belongs to Figure 1A ).
Supplemental Figures S2 & S3
Multiple sequence alignments showing the conservation of Scc1 binding to Pds5 and Scc3 (belongs to Figure 1C ).
Supplemental Figure S4
Lethality analysis of Pds5 and Scc1 mutants, validating the structure of the complex of Pds5 and Scc1 (belongs to Figure 2A &B).
Supplemental Figure S5
Control experiments supporting the ChIP-seq experiment in Figure 2C .
Supplemental Figure S6
Superposition of parts of the Pds5 and previous Scc3 structures, supporting Figure 3C .
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Supplemental References
Supplementary Figure S3 . Multiple sequence alignment showing conserved Scc3 binding regions within Scc1 kleisins from humans to yeast. Related to Figures 1C and 3C . 500 sequences similar to human and yeast Scc1 were selected by BLAST and all sequences (including from L. thermotolerans) were aligned by Clustal Omega. The alignment was truncated to 60 sequences without re-aligning. Resides 326-400 are shown for the Scc3 binding site in Scc1 corresponding to the fragment co-crystallised with SA2/Scc3 previously (Lt numbering; LtScc1 is the last sequence in the alignment.). Note that helix B is most likely missing from the Scc1 fragment in yeasts and related organisms but otherwise the alignment indicates that the binding mode of Scc1 to Scc3 is conserved. Figure S4 . S. cerevisiae Pds5(Y458K) growth tests. Related to Figures 2A & B . Wild type cells (K699, see list of strains) and cells with the endogenous PDS5 locus deleted and expressing PDS5 WT (K25118) or pds5 (Y458K) (K25126) integrated at the lys2 locus were streaked on YEPD plates and incubated at different temperatures. Note that ScPds5 Y458 corresponds to LtPds5 Y493 (labelled in Figure 1D ). Figure 3C . The LtPds5 structure was divided into four domains (left) that were independently aligned in 3D (PyMOL 1.7.6.2 'cealign' and 'align' commands) against the entire Scc3 (PDB 4UVK, middle) and SA2 (PDB 4PJU, right) structures. No manual adjustments were made. Two parts of Pds5 align reasonably well against their corresponding parts in both Scc3 and SA2. The C-terminal domain aligns less well and does not superimpose at all close to the C-terminus. It should be noted that the aligning parts show the highest conservation of the canonical HEAT repeat fold.
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Cloning, overexpression and purification
Lachancea thermotolerans CBS6340 Pds5 (LtPds5, NCBI database identifier XP_002553028.1) was expressed in E. coli using a codon-optimised synthetic gene (Epoch Lifescience, TX). Two constructs were used, LtPds5-1, amino acids 35-1221, approx.. 137 kDa and LtPds5-2, amino acids 45-1221, approx. 135 kDa (see Table 1 ). These were cloned into expression vector pHis17 using Gibson assembly (New England Biolabs, MA), adding the affinity purification tag LtPds5 proteins were expressed using a published feedback inhibition procedure (van den Ent et al., 1999; Van Duyne et al., 1993) and purified using the same protocol for the native proteins. All purifications were performed at 4˚C. The LtScc1 (NCBI database identifier XP_002555756.1) peptide (residues 121-143: LTNPSQYLLQDAVTEREVLLVPG) design was informed by published results (Chan et al., 2013) . Two otherwise identical, selenomethionine-substituted mutant peptides, Y127SeMet and L128SeMet, were used to confirm the orientation of Scc1 polypeptide. All peptides were chemically synthesised (Generon, UK, Cambridge Peptides, UK, and Genscript, USA/Hong Kong).
Crystallisation and data collection
Initial crystallisation experiments were carried out using sitting-drop vapour diffusion with LMB's in-house high-throughput crystallisation facility at 100 nl volumes (Stock et al., 2005) . LtPds5-2 protein (amino acids 45-1221) was crystallised with reservoir solutions containing 100 mM HEPES pH 7.5, and 1.3- 
Structure determination
Diffraction data were integrated and scaled with XDS (Kabsch, 2010) and SCALA (Winn et al., 2011) . Phasing was done by SeMet SAD combining data from two separate crystals in order to increase multiplicity and anomalous signal. Selenium positions were identified and SAD phases were calculated using SHELXC/D/E (Sheldrick, 2008) and PHASER (McCoy et al., 2007) . An initial atomic model was obtained using Crank2 (Skubak and Pannu, 2013) , and manually improved using COOT (Emsley et al., 2010) and MAIN (Turk, 2013) .
For refinement, the high resolution native apo dataset (Table 1) was corrected for anisotropy using the UCLA Diffraction Anisotropy Server (services.mbi.ucla.edu/anisoscale/) (Strong et al., 2006) , and the model was further rebuilt and refined in cycles at 3.2 Å resolution, manually rebuilt as above and refined with REFMAC (Murshudov et al., 1997) and PHENIX (Adams et al., 2010) . The LtPds5-LtScc1 complex dataset was even more anisotropic and was also corrected using the UCLA server. Data extended to 3.5 Å in two directions (Table 1 ) and 4.5 in the third, leading to an estimate of overall resolution of 3.6 Å. Note that dataset statistics listed in Table 1 are those of the uncorrected data at 3.6 Å resolution before applying anisotropy correction. The complex structure was solved by molecular replacement with PHASER. Due to overall conformational changes between apo-Pds5 and the Pds5-Scc1 complex structures, molecular replacement was performed with the apo structure cut into 4 roughly equal sized subdomains. After improving the atomic model of Pds5 within the complex structure by manual building and refinement as described above, strong extra electron density was located and the LtScc1 peptide was fitted. Modelling of the Scc1 sequence at this low resolution was guided by two additional selenium SAD experiments (details of data not shown) using peptides containing SeMet residues in two positions: LtScc1 (Y127SeMet) and LtScc1(L128SeMet). Phases were calculated using ANODE (Thorn and Sheldrick, 2011) and the refined Pds5 structure in the complex crystals. The entire model was then built and refined in cycles as for the apo structure. For Rfactors and other statistics of the data and models, please refer to Table 1. Because of low resolution, no waters or ions were added to any of the structures. 
Cell viability analysis of S. cerevisiae Pds5 and Scc1 mutants
The corresponding residues in S. cerevisiae Pds5 and Scc1 were located by sequence alignments. Mutant versions of Pds5 (under its native promoter) were incorporated at the lys2 locus in heterozygous PDS5/pds5Δ diploid cells (K25105, see List of Strains in Supplementary Data). Diploids were sporulated on SpoVB media plates and tetrads dissected at 25°C on YPD media plates. The genotype of the resulting haploids was determined by replica plating, and viable cells with only the ectopic copy were additionally tested for temperature sensitivity streaking cells on YEP glucose plates at 25°C, 30°C and 37°C ( Figure S4 ). Mutant versions of scc1 (under its native promoter) were incorporated at the leu2 locus in heterozygous SCC1/scc1D diploid cells (K12714) and analysed in a similar manner. All mutations were confirmed by DNA sequencing.
Co-immunoprecipitations
Strains were grown in YEPD at 25°C to OD600nm = 0.7 and 70 OD units were washed in ice-cold PBS and frozen at -80°C. Pellets were thawed and resuspended in lysis buffer (50 mM Tris/HCl, 100 mM NaCl, 5 mM EDTA, 1 mM DTT, 1 mM PMSF, Roche Complete Protease Inhibitors) and lysed in a FastPrep-24 (MP Biomedicals) disruptor 3 times for 1 min at 5.5 m/s with an equal volume of acid-washed glass beads (Sigma). Lysates were cleared by centrifugation at 13 Krpm for 30 min at 4°C and the protein amount of the supernatant was quantified with a Bradford assay. For cohesion immuneprecipitation, 150 µl of washed anti-HA High Affinity Matrix (Roche) was added to the cleared lysates and incubated over night at 4°C while rotating. The incubated anti-HA High Affinity Matrix was washed 3 times with 1 ml of lysis buffer, re-suspended in 60 µl of SDS-PAGE sample buffer and incubated at 95 °C for 10 min. 10 µl of each sample was loaded onto a precast Tris-acetate gel (3-8%, NuPAGE), followed by Western blotting and immunodetection of the PK epitopes with anti-PK antibody (AbD Serotec) and the HA epitopes with anti HA antibody (12CA5).
Calibrated ChIP-seq analysis
Calibrated ChIP-seq was performed as described (Hu et al., 2015) using K23308, K699, K25120 and K25128 strains for this assay.
